Our Pricing

Cheapest Place to Buy Wegovy: UK Weight Loss Results

Published on: June 03, 2026

Finding the cheapest place to buy Wegovy UK doesn't mean compromising on quality or clinical care. At Cured Pharmacy, Wegovy (semaglutide) starts from £79.00 with transparent upfront pricing, a free online consultation with UK prescribers, and discreet next-day delivery across the UK.

How Wegovy Delivers Clinical Weight Loss Results

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics the natural hormone GLP-1, which regulates appetite and food intake by acting on brain regions that control hunger.

In the landmark STEP 1 trial, participants receiving Wegovy 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group [1]. These results represent some of the most significant weight loss outcomes observed in clinical trials for obesity medications, with two-thirds of participants losing at least 10% of their baseline body weight [2].

Wegovy Dosing Schedule and Treatment Timeline

Wegovy follows a gradual dose escalation protocol designed to minimise gastrointestinal side effects while optimising therapeutic outcomes. Treatment begins with 0.25mg once weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [3].

The full dose escalation takes approximately 16-20 weeks, allowing your body to adjust to the medication progressively. UK prescribers may adjust this timeline based on individual tolerance and response. Most patients begin noticing appetite reduction within the first two weeks, with measurable weight loss typically evident by week 4-8 of treatment [3].

What to Expect During Treatment

Clinical trials demonstrate that weight loss continues throughout the first year of treatment, with the most significant reductions occurring between months 3-9 [1]. Your UK prescriber will monitor your progress through regular check-ins, adjusting treatment as needed to ensure both safety and efficacy. All prescription renewals at Cured Pharmacy include clinical review to assess ongoing suitability.

Wegovy vs Mounjaro: Comparing UK Weight Loss Injections

Both Wegovy and Mounjaro are once-weekly injectable medications licensed in the UK for weight management, but they work through different mechanisms. Wegovy activates GLP-1 receptors exclusively, while Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, targeting two complementary pathways involved in metabolism and appetite regulation.

Head-to-head trial data from the SURPASS-2 study showed that tirzepatide produced greater average weight loss than semaglutide 1mg, with the highest tirzepatide dose achieving 22.5% body weight reduction compared to 15.8% for semaglutide participants over 72 weeks [4]. However, individual response varies significantly, and both medications require prescription assessment by a UK clinician who will consider your medical history, current medications, and treatment goals.

Choosing Between Wegovy and Mounjaro

Your UK prescriber will assess factors including your BMI, weight loss goals, previous treatment responses, and any contraindications when recommending between these medications. Some patients may start with one treatment and switch to another based on tolerance or efficacy. At Cured Pharmacy, transparent pricing for both options allows you to make informed decisions alongside your prescriber's clinical guidance.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Wegovy are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. In clinical trials, these effects were generally mild to moderate and decreased over time as patients adjusted to the medication [1][2].

Nausea affected approximately 44% of participants in the STEP trials, though severe cases were uncommon and most resolved within weeks of dose stabilisation [2]. To minimise gastrointestinal symptoms, UK prescribers recommend eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week. If side effects persist or worsen, your prescriber may slow dose escalation or adjust your treatment plan.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis, or symptoms of thyroid tumours such as a lump in the neck or difficulty swallowing. Your Cured Pharmacy clinical team remains available for guidance throughout your treatment journey, with pharmacist support accessible via phone during business hours.

Who Can Use Wegovy in the UK

Wegovy is licensed in the UK for adults with an initial BMI of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. UK prescribers must assess your full medical history before prescribing, as certain conditions contraindicate semaglutide use.

Wegovy is not suitable if you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, diabetic retinopathy, or if you are pregnant or breastfeeding [3]. Your online consultation at Cured Pharmacy includes comprehensive screening questions to ensure Wegovy is clinically appropriate and safe for you. All prescription decisions are made by UK-registered prescribers in accordance with MHRA guidance and GMC standards.

Why Cured Pharmacy Offers the Cheapest Wegovy UK Pricing

At Cured Pharmacy, Wegovy starts from £79.00, representing competitive UK pricing with full transparency before you begin your consultation. Unlike some providers who reveal costs only after assessment, our upfront pricing policy ensures you can make informed financial decisions from the outset. All prices include UK prescriber consultation, with no hidden fees or subscription traps.

As a fully registered UK pharmacy (GPhC 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we source all medications directly from licensed UK wholesalers, guaranteeing genuine MHRA-approved products. Our efficient online model eliminates unnecessary overhead costs, allowing us to pass savings directly to patients whilst maintaining the highest standards of pharmaceutical care and regulatory compliance. Every Wegovy pen is dispensed with full patient information leaflets and access to our clinical support team throughout your treatment.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and cannot be guaranteed.